Detalhe da pesquisa
1.
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis.
Hepatology
; 79(3): 690-703, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625144
2.
The Role of Off-Therapy Viral Kinetics in the Timing and Severity of Flares in Hepatitis B e Antigen-Negative Patients.
Clin Gastroenterol Hepatol
; 21(6): 1533-1541.e11, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038130
3.
Off-tenofovir hepatitis flares in HBeAg-negative patients occur earlier, more frequent and severe than those off-entecavir therapies.
Liver Int
; 42(3): 551-560, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936719
4.
Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof-of-concept study.
Hepatol Res
; 52(10): 817-823, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716249
5.
A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study.
J Gastroenterol Hepatol
; 37(11): 2164-2172, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869752
6.
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses.
Int J Mol Sci
; 23(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163476
7.
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
Semin Liver Dis
; 41(3): 349-357, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182587
8.
Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare, with and without retreatment.
J Antimicrob Chemother
; 77(1): 205-212, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618028
9.
The impact of hepatitis flare on HBeAg loss was effective mainly in the first year of Nucleot(s)ide therapy in chronic hepatitis B.
J Viral Hepat
; 28(3): 475-483, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274536
10.
Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection.
Clin Gastroenterol Hepatol
; 18(9): 2064-2072.e2, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31982607
11.
Re-treatment for severe hepatitis flare in HBeAg-negative chronic hepatitis B: An appraisal with combined HBsAg/ALT kinetics.
J Viral Hepat
; 27(5): 544-547, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868280
12.
Reply: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect, or residual confounding?
Hepatology
; 79(3): E97-E98, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862454
13.
Reply: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
Hepatology
; 79(4): E109-E110, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906680
14.
Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
Hepatology
; 79(5): E134-E135, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150032
15.
Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival.
Hepatology
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38836640
16.
Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy.
Gastroenterology
; 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866763
17.
Remote and Short-Term Prediction of Spontaneous Hepatitis B Surface Antigen Seroclearance.
Gastroenterology
; 165(3): 805, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37094662
18.
Hepatitis B Surface Antigen Kinetics After Tenofovir Withdrawal in Chronic Hepatitis B.
Am J Gastroenterol
; 119(2): 389-390, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305791
19.
Off-therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg-negative patients.
J Viral Hepat
; 26(8): 1019-1026, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009126
20.
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.
J Viral Hepat
; 26(9): 1040-1049, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972912